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Temporary Decrease in Human Rabies Vaccine Supplies
The Centers for Disease Control and Prevention (CDC) has been notified that Novartis Vaccines, maker of 
RabAvert (Rabies Vaccine), will temporarily cease to provide their rabies vaccine for both pre- and post-exposure 
prophylaxis uses to health care providers. This includes physicians, nurse practitioners, hospitals, clinics, etc. A 
second company, Sanofi Pasteur, produces IMOVAX Rabies (Rabies Vaccine), and will continue to supply 
vaccine to health care providers for post-exposure prophylaxis (PEP). In certain circumstances, such as an 
allergic reaction to one company's vaccine product, the other company's vaccine product can be obtained to 
complete a vaccination series after consultation with state health departments and CDC, on a case-by-case basis. 
Overall, both manufacturers have limited supplies of rabies vaccine, necessitating the need for judicious use of 
these products by health care providers. (It is expected that additional RabAvert will be available on the market in 
July 2008. When that occurs, it is expected that the demand for pre-exposure vaccinations can be fully met with 
RabAvert.)
Due to temporarily limited supplies, distribution of vaccine for pre-exposure prophylaxis (PreP) will be approved 
by state and federal public health authorities. Priority will be given for those individuals at greatest rabies 
exposure risk (e.g., rabies laboratory workers, animal control officers, veterinary staff, wildlife workers) and in 
consideration of available rabies vaccine supplies. In lower risk rabies exposure categories (e.g., travelers, 
veterinary students, etc.), human rabies PreP should be delayed until vaccine supply levels are restored.
Priority use of rabies vaccine will be for post-exposure prophylaxis (PEP) following ACIP human rabies prevention 
recommendations (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5703a1.htm). IMOVAX rabies vaccine is 
available for PEP and providers should carefully review the ACIP recommendations and guidelines from their 
states to ensure that PEP is needed. They are also strongly encouraged to consult with local/state public health 
departments.
Public health authorities and health care providers are encouraged to educate the public concerning the need to 
take appropriate precautions to avoid rabies exposure and actions to take if an exposure occurs. Appropriate 
precautions include vaccination of pets, as well as livestock having close human contact, avoiding stray and wild 
animals, and safely capturing or detaining biting animals or obtaining owner contact information for follow up.
Such practices will decrease the need for rabies PEP and thus allow for the responsible management of currently 
limited vaccine supplies.
CDC is working closely with both vaccine companies and state and federal public health authorities to ensure that 
health care providers receive up to date information on supply fluxes. Discussions among federal, state, and local 
public health personnel are ongoing to review additional strategies to manage the current supply of rabies
vaccines. State and local health departments are working to ensure that health care providers are informed and 
have available consultation regarding best practices for the use of rabies vaccine.
Information about rabies, its prevention, and updates on the rabies vaccine situation can be obtained on the CDC 
rabies website http://www.cdc.gov/rabies/ or by calling 1-800-CDC-INFO. The rabies web site will be updated as 
new information becomes available.
The Centers fo r Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and in juries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships w ith local, national and international
organizations.
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